Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats
Background: MMPs/TIMPs system is well known to play important roles in pressure overload-induced cardiac remodeling, and Amlodipine and Atorvastatin have been showed to exert favourable protective effects on cardiovascular disease, however, it is not clear whether Amlodipine and Atorvastatin can imp...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-06-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/445604 |
_version_ | 1818993180777906176 |
---|---|
author | Jingchao Lu Jie Hao Hong Du Bing Xiao Yue Li Xiuchun Yang Wei Cui |
author_facet | Jingchao Lu Jie Hao Hong Du Bing Xiao Yue Li Xiuchun Yang Wei Cui |
author_sort | Jingchao Lu |
collection | DOAJ |
description | Background: MMPs/TIMPs system is well known to play important roles in pressure overload-induced cardiac remodeling, and Amlodipine and Atorvastatin have been showed to exert favourable protective effects on cardiovascular disease, however, it is not clear whether Amlodipine and Atorvastatin can improve hypertensive cardiac remodeling and whether the MMPs/TIMPs system is involved. The present study aims to answer these questions. Methods: 36 weeks old male spontaneous hypertension (SHR) rats were randomly divided into four groups: 1). SHR control group, 2). Amlodipine alone (10 mg/kg/d) group, 3). Atorvastatin alone (10 mg/kg/d) group, 4).Combination of Amlodipine and Atorvastatin (10 mg/kg/d for each) group. Same gender, weight and age of Wistar-Kyoto (WKY) rats with normal blood pressure were used as normal control. Drugs were administered by oral gavage over 12 weeks. The blood pressure and left ventricle mass index were measured. Enzyme activity of MMP-2 and MMP-9 was assessed with Gelatin zymography. MMP-2, MMP-9, TIMP-1 and TIMP-2 mRNA and protein expression was studied by RT-PCR and Western blot. Single factor ANOVA and LSD-t test were used in statistical analysis. Results: Treatment with Amlodipine alone or combination with atorvastatin significantly decreased blood pressure, left ventricle mass index in SHR rats (P Conclusion: Amlodipine and Atorvastatin could improve ventricular remodeling in SHR rats through intervention with the imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 system. |
first_indexed | 2024-12-20T20:37:58Z |
format | Article |
id | doaj.art-2d22ffcd74514fe4a6a31b8921a31fb9 |
institution | Directory Open Access Journal |
issn | 1015-8987 1421-9778 |
language | English |
last_indexed | 2024-12-20T20:37:58Z |
publishDate | 2016-06-01 |
publisher | Cell Physiol Biochem Press GmbH & Co KG |
record_format | Article |
series | Cellular Physiology and Biochemistry |
spelling | doaj.art-2d22ffcd74514fe4a6a31b8921a31fb92022-12-21T19:27:11ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-06-01391476010.1159/000445604445604Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR RatsJingchao LuJie HaoHong DuBing XiaoYue LiXiuchun YangWei CuiBackground: MMPs/TIMPs system is well known to play important roles in pressure overload-induced cardiac remodeling, and Amlodipine and Atorvastatin have been showed to exert favourable protective effects on cardiovascular disease, however, it is not clear whether Amlodipine and Atorvastatin can improve hypertensive cardiac remodeling and whether the MMPs/TIMPs system is involved. The present study aims to answer these questions. Methods: 36 weeks old male spontaneous hypertension (SHR) rats were randomly divided into four groups: 1). SHR control group, 2). Amlodipine alone (10 mg/kg/d) group, 3). Atorvastatin alone (10 mg/kg/d) group, 4).Combination of Amlodipine and Atorvastatin (10 mg/kg/d for each) group. Same gender, weight and age of Wistar-Kyoto (WKY) rats with normal blood pressure were used as normal control. Drugs were administered by oral gavage over 12 weeks. The blood pressure and left ventricle mass index were measured. Enzyme activity of MMP-2 and MMP-9 was assessed with Gelatin zymography. MMP-2, MMP-9, TIMP-1 and TIMP-2 mRNA and protein expression was studied by RT-PCR and Western blot. Single factor ANOVA and LSD-t test were used in statistical analysis. Results: Treatment with Amlodipine alone or combination with atorvastatin significantly decreased blood pressure, left ventricle mass index in SHR rats (P Conclusion: Amlodipine and Atorvastatin could improve ventricular remodeling in SHR rats through intervention with the imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 system.http://www.karger.com/Article/FullText/445604Matrix metalloproteinasesTissue inhibitors of matrix metalloproteinasesAmlodipineAtorvastatinCardiac hypertrophySpontaneous hypertension |
spellingShingle | Jingchao Lu Jie Hao Hong Du Bing Xiao Yue Li Xiuchun Yang Wei Cui Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats Cellular Physiology and Biochemistry Matrix metalloproteinases Tissue inhibitors of matrix metalloproteinases Amlodipine Atorvastatin Cardiac hypertrophy Spontaneous hypertension |
title | Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats |
title_full | Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats |
title_fullStr | Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats |
title_full_unstemmed | Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats |
title_short | Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats |
title_sort | amlodipine and atorvastatin improved hypertensive cardiac remodeling through regulation of mmps timps in shr rats |
topic | Matrix metalloproteinases Tissue inhibitors of matrix metalloproteinases Amlodipine Atorvastatin Cardiac hypertrophy Spontaneous hypertension |
url | http://www.karger.com/Article/FullText/445604 |
work_keys_str_mv | AT jingchaolu amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT jiehao amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT hongdu amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT bingxiao amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT yueli amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT xiuchunyang amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats AT weicui amlodipineandatorvastatinimprovedhypertensivecardiacremodelingthroughregulationofmmpstimpsinshrrats |